Researchers from the University of Bath have developed fluorescent molecular probes that can detect changes in glucose levels ...
Opportunities span AI-enabled discovery, multi-omics, precision medicine, advanced therapies, biomarker-led trials, data platforms, CRO partnerships and Asia-Pacific expansionDublin, Sept. 22, 2026 ...
As can be seen, the Vivo X500 will be available in four shades, such as white, grey, dawn (pink), and black. The images show that the X500 has a different design compared to the Pro models. While the ...
Tatiana Munteanu was aiming to make light-activated molecular motors, part of a growing class of metamaterials that can perform tiny amounts of mechanical work. Along the way, though, a synthetic ...
For years, a battlefield test sat in the background of the war in Ukraine. On June 10 it surfaced publicly: a report claims that Ukrainian forces tested drones that, once switched to ‘Terminator mode, ...
The integration of synaptic inputs is a fundamental function of neurons. In the traditional model, excitatory inputs are summed at the soma to generate action potentials. However, how synaptic inputs ...
For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
J&J and Sail will advance the biotech's “vanguard” in vivo CAR-T program in autoimmune diseases. (Darren Incorvaia) Johnson & Johnson is cruising deeper into in vivo CAR-T waters, paying $785 million ...
Hospitals are rethinking their operations and infrastructure for electrophysiology services amid the specialty’s rapid growth. Electrophysiology is a specialty within cardiology through which the ...
Moderna has unveiled its first in vivo CAR-T program. Building on other groups’ ex vivo CAR-T data, the company plans to start clinical development of an off-the-shelf autoimmune disease prospect, ...